Compagnie Lombard Odier SCmA’s Abiomed Inc ABMD Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-330	Closed	-$148K	–	618
2018 Q3	$148K	Buy	330 +50	+18%	+$19.7K	0.01%	322
2018 Q2	$115K	Buy	280 +200	+250%	+$72.5K	﹤0.01%	343
2018 Q1	$23K	Sell	80 -80	-50%	-$20.3K	﹤0.01%	516
2017 Q4	$30K	Buy	160 +80	+100%	+$14.9K	﹤0.01%	566
2017 Q3	$13K	Hold	80	–	–	﹤0.01%	630
2017 Q2	$11K	Hold	80	–	–	﹤0.01%	650
2017 Q1	$10K	Hold	80	–	–	﹤0.01%	675
2016 Q4	$9K	Hold	80	–	–	﹤0.01%	757
2016 Q3	$10K	Hold	80	–	–	﹤0.01%	846
2016 Q2	$9K	Hold	80	–	–	﹤0.01%	842
2016 Q1	$8K	Hold	80	–	–	﹤0.01%	905
2015 Q4	$7K	Hold	80	–	–	﹤0.01%	880
2015 Q3	$7K	Hold	80	–	–	﹤0.01%	769
2015 Q2	$5K	Hold	80	–	–	﹤0.01%	789
2015 Q1	$6K	Sell	80 -70	-47%	-$3.8K	﹤0.01%	917
2014 Q4	$6K	Hold	150	–	–	﹤0.01%	735
2014 Q3	$4K	Hold	150	–	–	﹤0.01%	846
2014 Q2	$4K	Hold	150	–	–	﹤0.01%	863
2014 Q1	$4K	Hold	150	–	–	﹤0.01%	849
2013 Q4	$4K	Buy	+150	New	+$3.71K	﹤0.01%	837

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Compagnie Lombard Odier SCmA's ABMD Position: Q4 2018 in Review

Compagnie Lombard Odier SCmA sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 330 shares — an estimated $148K sold.

Compagnie Lombard Odier SCmA first reported a position in ABMD in Q4 2013 and held it in 20 quarters. The position peaked at $148K in Q3 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

Compagnie Lombard Odier SCmA reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 330 Abiomed Inc shares in Q4 2018, an estimated $148K.
Compagnie Lombard Odier SCmA first reported a position in Abiomed Inc in Q4 2013 and held it in 20 quarters.
Compagnie Lombard Odier SCmA's Abiomed Inc position peaked at $148K in Q3 2018.
529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2018, filed 13 Feb 2019.